These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3801416)

  • 1. Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase.
    Kruse LI; DeWolf WE; Chambers PA; Goodhart PJ
    Biochemistry; 1986 Nov; 25(23):7271-8. PubMed ID: 3801416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisubstrate inhibitors of dopamine beta-hydroxylase. 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Garvey E; Hilbert EL; Faulkner WA; Flaim KE; Sawyer JL; Berkowitz BA
    J Med Chem; 1986 Dec; 29(12):2465-72. PubMed ID: 3783606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols.
    Goodhart PJ; DeWolf WE; Kruse LI
    Biochemistry; 1987 May; 26(9):2576-83. PubMed ID: 3607034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site.
    Kruse LI; Kaiser C; DeWolf WE; Frazee JS; Ross ST; Wawro J; Wise M; Flaim KE; Sawyer JL; Erickson RW
    J Med Chem; 1987 Mar; 30(3):486-94. PubMed ID: 3820219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine beta-hydroxylase. 4. Structure-activity relationships at the copper binding site.
    Kruse LI; Kaiser C; DeWolf WE; Finkelstein JA; Frazee JS; Hilbert EL; Ross ST; Flaim KE; Sawyer JL
    J Med Chem; 1990 Feb; 33(2):781-9. PubMed ID: 2299645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The copper sites of dopamine beta-hydroxylase: an X-ray absorption spectroscopic study.
    Scott RA; Sullivan RJ; DeWolf WE; Dolle RE; Kruse LI
    Biochemistry; 1988 Jul; 27(15):5411-7. PubMed ID: 3179263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylase.
    McCarthy JR; Matthews DP; Broersma RJ; McDermott RD; Kastner PR; Hornsperger JM; Demeter DA; Weintraub HJ; Whitten JP
    J Med Chem; 1990 Jul; 33(7):1866-73. PubMed ID: 2362264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of dopamine beta-hydroxylase by beta-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide.
    DeWolf WE; Chambers PA; Southan C; Saunders D; Kruse LI
    Biochemistry; 1989 May; 28(9):3833-42. PubMed ID: 2751998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine beta-hydroxylase. Inactivation by a suicide substrate.
    Baldoni JM; Villafranca JJ
    J Biol Chem; 1980 Oct; 255(19):8987-90. PubMed ID: 7410403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based inhibition of dopamine beta-monooxygenase by aldehydes and amides.
    Bossard MJ; Klinman JP
    J Biol Chem; 1986 Dec; 261(35):16421-7. PubMed ID: 3782127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
    Sirimanne SR; May SW
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):77-85. PubMed ID: 7864832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inhibitors of dopamine beta-hydroxylase: inhibition by 2-bromo-3-(p-hydroxyphenyl)-1-propene.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    Biochemistry; 1984 Jul; 23(16):3590-8. PubMed ID: 6477886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetic properties of membrane dopamine-beta-hydroxylase. ].
    Miras Portugal MT; Jorda A; Santos Ruiz A
    FEBS Lett; 1976 Dec; 72(2):267-70. PubMed ID: 16386037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternate substrates of dopamine beta-hydroxylase. I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    J Biol Chem; 1984 Feb; 259(3):1593-600. PubMed ID: 6693426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbate based novel high affinity alternate reductants and competitive inhibitors of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S; Wimalasena DS
    Biochem Biophys Res Commun; 1994 Apr; 200(1):113-9. PubMed ID: 8166679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of dopamine beta-mono-oxygenase with substituted imidazoles and pyrazoles. Catalysis and inhibition.
    Sirimanne SR; Herman HH; May SW
    Biochem J; 1987 Feb; 242(1):227-33. PubMed ID: 3593236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and spectroscopic studies of the interaction of copper with dopamine beta-hydroxylase.
    Ash DE; Papadopoulos NJ; Colombo G; Villafranca JJ
    J Biol Chem; 1984 Mar; 259(6):3395-8. PubMed ID: 6323422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.